Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1132 | 980 | 1265 | 929 | 1096 | 1583 |
Fund Return | 13.2% | -1.98% | 26.5% | -2.42% | 1.84% | 4.7% |
Place in category | 7 | 59 | 10 | 76 | 83 | 38 |
% in Category | 3 | 55 | 5 | 69 | 85 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Sycomore Selection Responsable i | 717.49M | 12.52 | 3.50 | 7.55 | ||
Sycomore Selection Responsable RP | 717.49M | 11.53 | 2.45 | 6.47 | ||
Sycomore Selection Responsable R | 717.49M | 11.65 | 2.49 | 6.48 | ||
Sycomore European Growth A | 237.37M | 12.72 | -2.90 | 4.14 | ||
Sycomore European Growth R | 237.37M | 12.26 | -3.39 | 3.69 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Prevoir Gestion Actions I | 369.93M | 9.30 | -4.34 | 10.53 | ||
Prevoir Gestion Actions C | 369.93M | 8.57 | -5.10 | 9.66 | ||
Covea Actions Croissance D | 234.57M | -1.56 | -3.25 | 6.93 | ||
Covea Actions Croissance C | 234.57M | -1.57 | -3.25 | 6.78 | ||
Sycomore European Growth A | 237.37M | 12.72 | -2.90 | 4.14 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 6.25 | 638.00 | +1.03% | |
AXA | FR0000120628 | 4.92 | 33.74 | -1.35% | |
Deutsche Telekom AG | DE0005557508 | 4.60 | 29.043 | +0.29% | |
Sanofi | FR0000120578 | 4.20 | 91.78 | +1.00% | |
Schneider Electric | FR0000121972 | 4.18 | 239.35 | -0.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review